Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11134
Title: Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.
Austin Authors: Torresi, Joseph ;McCarthy, Karen;Feroldi, Emmanuel;Méric, Claude
Affiliation: Infectious Diseases
Issue Date: 8-Oct-2010
Publication information: Vaccine 2010; 28(50): 7993-8000
Abstract: Japanese encephalitis chimeric virus vaccine (JE-CV) was developed to replace licensed mouse brain-derived vaccine (MBD-JE), the production of which ceased in 2005. Two randomised controlled phase 3 studies were conducted. Immunogenicity study: 410 participants received one JE-CV injection, 410 received 3 MBD-JE injections. Safety study: 1,601 participants received JE-CV, 403 received placebo. Seroconversion after a single JE-CV vaccination (99.1%) was statistically non-inferior to that after three-dose MBD-JE (95.1%) vaccination. JE-CV elicited a rapid immune response, with 93.6% of participants seroconverting within 14 days. Adverse reaction rates were significantly lower with JE-CV (67.6%) than with MBD-JE (82.2%) (p<0.001), and the reactogenicity profile of JE-CV was comparable with that of placebo. A single dose of JE-CV elicited rapid seroconversion in a higher proportion of vaccinees than the current vaccine with fewer reactions. The safety profile of JE-CV is good.
URI: https://ahro.austin.org.au/austinjspui/handle/1/11134
DOI: 10.1016/j.vaccine.2010.09.035
ORCID: 
Journal: Vaccine
URL: https://pubmed.ncbi.nlm.nih.gov/20934459
Type: Journal Article
Subjects: Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Neutralizing.blood
Antibodies, Viral.blood
Double-Blind Method
Encephalitis, Japanese.prevention & control
Female
Humans
Japanese Encephalitis Vaccines.administration & dosage.adverse effects.immunology
Male
Middle Aged
Neutralization Tests
Vaccines, Attenuated.administration & dosage.adverse effects.immunology
Young Adult
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on Mar 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.